Illicit Injectable Peptides—Re... Note

Illicit Injectable Peptides—Reply

In Reply We thank Dr Janovsky for highlighting the emergence of illicit peptide markets in Brazil and for extending the discussion beyond the jurisdictions considered in our original Viewpoint. Janovsky’s observations reinforce our central argument that the rapid expansion of unapproved peptide use is no longer a country-specific regulatory issue, but an increasingly global public health challenge. The Brazilian experience is striking because it mirrors patterns emerging elsewhere. Illicit peptides are increasingly marketed online using remarkably consistent narratives centered on recovery, muscle growth, healthy aging, and health optimization, despite limited human evidence supporting these claims. As Janovsky notes, concerns extend beyond efficacy to product quality, manufacturing standards, and unsupported therapeutic claims.